Your browser doesn't support javascript.
loading
Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial.
Zarski, Anna-Carlotta; Weisel, Kiona K; Berger, Thomas; Krieger, Tobias; Schaub, Michael P; Berking, Matthias; Görlich, Dennis; Jacobi, Corinna; Ebert, David D.
  • Zarski AC; Division of eHealth in Clinical Psychology, Department of Clinical Psychology, Philipps University of Marburg, Marburg, Germany.
  • Weisel KK; Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Berger T; Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Krieger T; Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.
  • Schaub MP; Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.
  • Berking M; Swiss Research Institute for Public Health and Addiction (ISGF), Associated to the University of Zurich, Zurich, Switzerland.
  • Görlich D; Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Jacobi C; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Ebert DD; Institute for Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany.
Psychother Psychosom ; 93(3): 155-168, 2024.
Article en En | MEDLINE | ID: mdl-38688243
ABSTRACT

INTRODUCTION:

Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms.

OBJECTIVE:

This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive symptom severity with either individualized (IG-IMI) or automated (AG-IMI) guidance compared to a waitlist control group with care-as-usual access (WLC).

METHODS:

Participants included 566 adults with subclinical anxiety (GAD-7 ≥ 5) and/or depressive (CES-D ≥16) symptoms, who did not meet criteria for a full-syndrome depressive or anxiety disorder. In a three-arm randomized clinical trial, participants were randomized to a cognitive behavioral 7-session IMI plus booster session with IG-IMI (n = 186) or AG-IMI (n = 189) or WLC (n = 191). Primary outcomes included observer-rated anxiety (HAM-A) and depressive (QIDS) symptom severity 8 weeks after randomization assessed by blinded raters via telephone. Follow-up outcomes at 6 and 12 months are reported.

RESULTS:

Symptom severity was significantly lower with small to medium effects in IG-IMI (anxiety d = 0.45, depression d = 0.43) and AG-IMI (anxiety d = 0.31, depression d = 0.32) compared to WLC. No significant differences emerged between guidance formats in primary outcomes. There was a significant effect in HAM-A after 6 months favoring AG-IMI. On average, participants completed 85.38% of IG-IMI and 77.38% of AG-IMI.

CONCLUSIONS:

A transdiagnostic, self-tailored IMI can reduce subclinical anxiety and depressive symptom severity, but 12-month long-term effects were absent. Automated guidance holds promise for enhancing the scalability of IMIs in broad prevention initiatives.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Depresión / Intervención basada en la Internet Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Depresión / Intervención basada en la Internet Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article